The role of anthracyclines in the treatment of gastric cancer

This publication has 32 references indexed in Scilit:

• A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin
  JAMA, 1985
• Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with upper gastrointestinal tumors
  American Journal of Clinical Oncology, 1983
• A phase II study of cisplatin in advanced gastric cancer
  European Journal of Cancer and Clinical Oncology, 1983
• Combination adriamycin/misonidazole toxicity in V79 spheroids
  International Journal of Radiation Oncology*Biology*Physics, 1982
• Preliminary Clinical Experience with 4’-Epidoxorubicin in Advanced Human Neoplasia
  Published by Springer Nature ,1980
• 5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer. A Southwest oncology group study
  Cancer, 1979
• Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU.A southwest oncology group study
  Cancer, 1976
• Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNA
  Journal of Pharmacy and Pharmacology, 1976
• Integration of chemotherapy into combined modality treatment of solid tumors: III. Gastric cancer
  Cancer Treatment Reviews, 1974
• FLUOROURACIL AND RADIOTHERAPY IN GASTROINTESTINAL CANCER
  The Lancet, 1969